Single Cell Transciptomics of the Opioid Use Disorder and HIV Syndemic in the Human Brain
人脑中阿片类药物使用障碍和艾滋病毒综合症的单细胞转录组学
基本信息
- 批准号:10670632
- 负责人:
- 金额:$ 95.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAcquired Immunodeficiency SyndromeAddictive BehaviorAffectAmygdaloid structureAstrocytesBrainBrain regionCell NucleusCellsChronicClinicalClustered Regularly Interspaced Short Palindromic RepeatsComputer AnalysisCorpus striatum structureData SetDatabasesDevelopmentDiseaseDrug AddictionDrug usageEventExhibitsExposure toFamilyGene ExpressionGenesHIVHIV InfectionsHIV-1HIV-associated neurocognitive disorderHumanImmunohistochemistryImmunosuppressionIn VitroIncidenceIndividualInfectionInflammationInflammatoryKnock-outLeadLifeLinkMicrogliaMolecularMorphineNeurogliaNeurologicNeuronal InjuryNeuronsNucleus AccumbensOpioidOrganoidsPathogenesisPathologyPathway interactionsPatientsPatternPersonsPharmaceutical PreparationsPhenotypePopulationPrefrontal CortexPrimary InfectionPublic HealthResearchRouteSamplingSliceSmall Nuclear RNASocial ImpactsSubstance Use DisorderTechnologyTestingTissue-Specific Gene ExpressionTranscriptValidationVariantViral Load resultViral reservoiracute infectionaddictionantiretroviral therapybasebrain cellbrain tissuecell typechronic inflammatory diseasedifferential expressioneconomic impactepigenetic regulationgene regulatory networkgene therapyimmune activationin vivoinduced pluripotent stem celllead candidateneurocognitive disordernew technologynovelopioid misuseopioid use disorderresilienceresponseseroconversionsyndemicthree dimensional cell culturetranscriptometranscriptome sequencingtranscriptomics
项目摘要
PROJECT SUMMARY
Persistent immune activation is the defining feature of HIV-1 infection in vivo and a driver of progression
to end-stage AIDS. Systemic immune activation in people living with HIV has been hypothesized to
account for higher incidence of chronic inflammatory diseases, including HIV-associated neurocognitive
disorders (HAND). While significant neurological complications associated with HIV-1 infection occur
years after seroconversion and is commonly coincident with progressive immunosuppression and high
viral loads, establishment of a virus reservoir in the CNS occurs with primary infection. Furthermore, acute
infection in the CNS is thought to initiate a cascade of pro-inflammatory events that result in inflammation-
induced neuronal injury and associated neurocognitive disorders that are evident even in the present
combination antiretroviral therapy (cART) era. Approximately 12 million people inject drugs globally, 13%
of these are people living with HIV. Opioid misuse is a route of HIV acquisition and a barrier to effective
antiretroviral therapy (ART). However, it is unclear whether opioid misuse changes the course of HIV
pathogenesis, especially on HIV-associated neurocognitive disorders. Our central hypothesis is that
opioid misuse exacerbates HIV pathogenesis in the CNS by dysregulating the glial population in the brain.
Our overall objective is to exploit cell type specific transcriptomic information at the single nuclei level from
patient brain samples to characterize the effects of opioid use disorder on CNS neuronal and glial cells,
HIV infection and HANDs. We will characterize single nuclei gene expression and identify dysregulated
gene regulatory networks in each of the neuronal and glial populations associated with opioid misuse in
HIV infected individuals and/or with HANDs. We will also perform computational analysis to identify
neuronal and glial cell regulatory networks altered by opioid misuse. In the validation component, we will
select the top 20 targets from single cell transcriptomics profiles, first validating with
immunohistochemistry with fixed brain tissue, then selecting a few top targets and using 2D and 3D
cultures of iPS derived neurons, microglia and astrocytes to characterize functionality with CRISPR
knockout. Successful completion of these aims will have significant research and clinical impact by 1)
elucidating how opioid misuse alters HIV/HAND pathogenesis in the CNS, and 2) discovering candidate
molecules to regulate HIV infection or persistence in the CNS in the context of opioid misuse.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christine Cheng其他文献
Christine Cheng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christine Cheng', 18)}}的其他基金
Single Cell Transciptomics of the Opioid Use Disorder and HIV Syndemic in the Human Brain
人脑中阿片类药物使用障碍和艾滋病毒综合症的单细胞转录组学
- 批准号:
10699022 - 财政年份:2022
- 资助金额:
$ 95.59万 - 项目类别:
Single Cell Transcriptomics of the Cocaine Use Disorder in the Context of HIV
HIV 背景下可卡因使用障碍的单细胞转录组学
- 批准号:
10644020 - 财政年份:2022
- 资助金额:
$ 95.59万 - 项目类别:
Single Cell Transcriptomics of the Cocaine Use Disorder in the Context of HIV
HIV 背景下可卡因使用障碍的单细胞转录组学
- 批准号:
10454684 - 财政年份:2022
- 资助金额:
$ 95.59万 - 项目类别:
Exploring the Pathophysiology of AD and ADRDs with 3D Asteroid Models
使用 3D 小行星模型探索 AD 和 ADRD 的病理生理学
- 批准号:
10459727 - 财政年份:2021
- 资助金额:
$ 95.59万 - 项目类别:
Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection
阿片类药物和 HIV 感染对小胶质细胞慢性先天免疫激活的协同机制
- 批准号:
10398922 - 财政年份:2020
- 资助金额:
$ 95.59万 - 项目类别:
Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection
阿片类药物和 HIV 感染对小胶质细胞慢性先天免疫激活的协同机制
- 批准号:
10206088 - 财政年份:2020
- 资助金额:
$ 95.59万 - 项目类别:
Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection
阿片类药物和 HIV 感染对小胶质细胞慢性先天免疫激活的协同机制
- 批准号:
10613922 - 财政年份:2020
- 资助金额:
$ 95.59万 - 项目类别:
Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection
阿片类药物和 HIV 感染对小胶质细胞慢性先天免疫激活的协同机制
- 批准号:
10055219 - 财政年份:2020
- 资助金额:
$ 95.59万 - 项目类别:
Single Cell Transcriptomics of the Opioid Use Disorder and HIV Syndemic in the Human Brain
人脑中阿片类药物使用障碍和艾滋病毒综合症的单细胞转录组学
- 批准号:
10296588 - 财政年份:2020
- 资助金额:
$ 95.59万 - 项目类别:
Single Cell Transcriptomics of the Opioid Use Disorder and HIV Syndemic in the Human Brain
人脑中阿片类药物使用障碍和艾滋病毒综合症的单细胞转录组学
- 批准号:
10241384 - 财政年份:2020
- 资助金额:
$ 95.59万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 95.59万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 95.59万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 95.59万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 95.59万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 95.59万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 95.59万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 95.59万 - 项目类别:














{{item.name}}会员




